User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 17:26, 9 March 2021 (diff | hist) . . (+19) . . 20.109(S21):Data Summary (→Implications and Future Work: potential topics)
- 17:14, 9 March 2021 (diff | hist) . . (+544) . . 20.109(S21):Data Summary (→Characterization of individual clone)
- 12:46, 9 March 2021 (diff | hist) . . (+318) . . 20.109(S21):M1D6 (→Part 2: Accuri Flow Cytometry of Stained Yeast Samples)
- 12:41, 9 March 2021 (diff | hist) . . (+1,388) . . 20.109(S21):M1D6 (→Part 2: Accuri Flow Cytometry of Stained Yeast Samples)
- 12:23, 9 March 2021 (diff | hist) . . (0) . . 20.109(S21):M1D6 (→Part 1: Prepare Titration Lysozyme with scFv Clone on Yeast)
- 12:21, 9 March 2021 (diff | hist) . . (+99) . . 20.109(S21):M1D6 (→Part 2: Accuri Flow Cytometry of Stained Yeast Samples)
- 12:19, 9 March 2021 (diff | hist) . . (+127) . . 20.109(S21):M1D6 (→Part 2: Accuri Flow Cytometry of Stained Yeast Samples)
- 16:42, 8 March 2021 (diff | hist) . . (-8) . . 20.109(S21):M1D6 (→Part 1: Prepare Titration Lysozyme with scFv Clone on Yeast)
- 16:35, 8 March 2021 (diff | hist) . . (0) . . 20.109(S21):M1D7 (→Protocols)
- 16:32, 8 March 2021 (diff | hist) . . (-92) . . 20.109(S21):M1D6 (→Protocols)
- 16:27, 8 March 2021 (diff | hist) . . (+4) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 16:27, 8 March 2021 (diff | hist) . . (-656) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 16:08, 8 March 2021 (diff | hist) . . (+1) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 16:06, 8 March 2021 (diff | hist) . . (+8) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 16:05, 8 March 2021 (diff | hist) . . (0) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 16:05, 8 March 2021 (diff | hist) . . (+6) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 16:04, 8 March 2021 (diff | hist) . . (-1) . . 20.109(S21):M1D6 (→Introduction: Characterize clone ligand binding using flow cytometry)
- 19:34, 5 March 2021 (diff | hist) . . (-1) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:33, 5 March 2021 (diff | hist) . . (-4) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:32, 5 March 2021 (diff | hist) . . (-3) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:30, 5 March 2021 (diff | hist) . . (+1) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:30, 5 March 2021 (diff | hist) . . (+5) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:26, 5 March 2021 (diff | hist) . . (+1) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:26, 5 March 2021 (diff | hist) . . (+1) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:25, 5 March 2021 (diff | hist) . . (-1) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:25, 5 March 2021 (diff | hist) . . (-2) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:24, 5 March 2021 (diff | hist) . . (+1) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:19, 5 March 2021 (diff | hist) . . (+13) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:18, 5 March 2021 (diff | hist) . . (-13) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:13, 5 March 2021 (diff | hist) . . (0) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:13, 5 March 2021 (diff | hist) . . (0) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:12, 5 March 2021 (diff | hist) . . (+2) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:08, 5 March 2021 (diff | hist) . . (-15) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:07, 5 March 2021 (diff | hist) . . (-2,413) . . 20.109(S21):M1D7 (→Introduction:Analyze ligand titration curves)
- 19:08, 4 March 2021 (diff | hist) . . (0) . . File:Sp21 Mod1 lecture 4.pdf (Leslie McClain uploaded a new version of "File:Sp21 Mod1 lecture 4.pdf") (current)
- 18:59, 4 March 2021 (diff | hist) . . (+5) . . 20.109(S21):Spring 2021 schedule
- 18:57, 4 March 2021 (diff | hist) . . (0) . . N File:Sp21 Mod1 lecture5marked.pdf (current)
- 15:43, 4 March 2021 (diff | hist) . . (+41) . . 20.109(S21):Spring 2021 schedule
- 15:43, 4 March 2021 (diff | hist) . . (0) . . N File:Sp21 Mod1 lecture 5.pdf (current)
- 20:31, 3 March 2021 (diff | hist) . . (-26) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:59, 3 March 2021 (diff | hist) . . (+213) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:54, 3 March 2021 (diff | hist) . . (+113) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:49, 3 March 2021 (diff | hist) . . (-109) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:47, 3 March 2021 (diff | hist) . . (+154) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:45, 3 March 2021 (diff | hist) . . (-67) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:42, 3 March 2021 (diff | hist) . . (-2) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:42, 3 March 2021 (diff | hist) . . (+55) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:20, 3 March 2021 (diff | hist) . . (-8) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:19, 3 March 2021 (diff | hist) . . (+30) . . 20.109(S21):M1D5 (→Part 2: Align scFv sequences)
- 16:16, 3 March 2021 (diff | hist) . . (+11) . . 20.109(S21):M1D5 (→Introduction:Analyze clone sequence and choose clone to characterize)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)